Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
10.39
-0.06 (-0.57%)
At close: Mar 28, 2025, 4:00 PM
10.46
+0.07 (0.65%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $800.18 million as of March 28, 2025. Its market cap has increased by 45.15% in one year.
Market Cap
800.18M
Enterprise Value
339.69M
1-Year Change
45.15%
Ranking
Category
Stock Price
$10.39
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $800.18M, an increase of 71.16%. That is a compound annual growth rate of 8.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |